These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11369890)

  • 1. Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation.
    Konishi K; Maruo S; Kato H; Takada K
    J Gen Virol; 2001 Jun; 82(Pt 6):1451-1456. PubMed ID: 11369890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection.
    Rechsteiner MP; Berger C; Zauner L; Sigrist JA; Weber M; Longnecker R; Bernasconi M; Nadal D
    J Virol; 2008 Feb; 82(4):1739-47. PubMed ID: 18057232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction.
    Swart R; Fruehling S; Longnecker R
    Virology; 1999 Oct; 263(2):485-95. PubMed ID: 10544120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction.
    Fruehling S; Lee SK; Herrold R; Frech B; Laux G; Kremmer E; Grässer FA; Longnecker R
    J Virol; 1996 Sep; 70(9):6216-26. PubMed ID: 8709248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.
    Miller CL; Lee JH; Kieff E; Longnecker R
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):772-6. PubMed ID: 8290598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice.
    Vrazo AC; Chauchard M; Raab-Traub N; Longnecker R
    PLoS Pathog; 2012; 8(4):e1002662. PubMed ID: 22536156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential.
    Longnecker R; Miller CL; Miao XQ; Marchini A; Kieff E
    J Virol; 1992 Nov; 66(11):6461-9. PubMed ID: 1328675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated disease.
    Portis T; Cooper L; Dennis P; Longnecker R
    Front Biosci; 2002 Feb; 7():d414-26. PubMed ID: 11815296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells.
    Rechsteiner MP; Berger C; Weber M; Sigrist JA; Nadal D; Bernasconi M
    J Gen Virol; 2007 May; 88(Pt 5):1454-1459. PubMed ID: 17412973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency.
    Rechsteiner MP; Bernasconi M; Berger C; Nadal D
    Trends Microbiol; 2008 Nov; 16(11):520-7. PubMed ID: 18835714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.
    Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R
    J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus LMP2A imposes sensitivity to apoptosis.
    Swanson-Mungerson M; Bultema R; Longnecker R
    J Gen Virol; 2010 Sep; 91(Pt 9):2197-202. PubMed ID: 20484564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency.
    Fruehling S; Swart R; Dolwick KM; Kremmer E; Longnecker R
    J Virol; 1998 Oct; 72(10):7796-806. PubMed ID: 9733815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.
    Steinbrück L; Gustems M; Medele S; Schulz TF; Lutter D; Hammerschmidt W
    J Virol; 2015 Jul; 89(14):7248-61. PubMed ID: 25948739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
    Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
    J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes.
    Miller CL; Longnecker R; Kieff E
    J Virol; 1993 Jun; 67(6):3087-94. PubMed ID: 7684459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.
    Incrocci R; Hussain S; Stone A; Bieging K; Alt LA; Fay MJ; Swanson-Mungerson M
    Cell Immunol; 2015 Oct; 297(2):108-19. PubMed ID: 26255694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins.
    Ikeda M; Ikeda A; Longnecker R
    J Virol; 2001 Jun; 75(12):5711-8. PubMed ID: 11356981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of host kinase activity altered by the LMP2A signalosome-a therapeutic target for Epstein-Barr virus latency and associated disease.
    Cooper L; Longnecker R
    Antiviral Res; 2002 Dec; 56(3):219-31. PubMed ID: 12406506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.
    Ma SD; Tsai MH; Romero-Masters JC; Ranheim EA; Huebner SM; Bristol JA; Delecluse HJ; Kenney SC
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.